Date of publication: September 20, 2016

Presentation Resources

Advances in the Management of Hyperphosphatemia

In this presentation, recorded at a satellite symposium at the ERA-EDTA 2016 Congress, Professor Philip Kalra discusses clinical advances in the management of hyperphosphatemia.

Topics covered include:

  • The prevalence of vascular calcification in both non-dialysis and dialysis-dependent CKD, and the link between vascular calcification and increased mortality
  • The associations between hyperphosphatemia, vascular calcification and increased mortality in CKD patients
  • Randomised controlled trials for phosphate binder interventions in CKD-MBD, including RIND, DCOR and Treat-to-Goal
  • Results from Phase III trials of sucroferric oxyhydroxide, as well as safety and efficacy data from long term extension studies
  • Real-wold data on sucroferric oxyhydroxide which has seen almost a doubling of the number of patients achieving their phosphate targets following a switch from other phosphate binders




Send us your feedback

Please take a moment to rate the educational activity you have just completed.

1. How useful was this activity for your clinical practice?

2. How useful did you find the format of the activity?

3. Would you recommend this activity to a colleague?

Leave a Reply


You are about to leave

Clicking the "Continue" link below will take you to an external website. Compact Renal is not responsible for the contents of any external website. Compact Renal is providing these links to you as a convenience, and the inclusion of any links does not imply endorsement of the linked site by Compact Renal.

Do you wish to continue?

Continue Cancel